Search Results
Aug 31, 2026, 06:30 ET NEVADA KING SECURES FOURTH DRILL RIG TO ATLANTA, PROVIDES EXPLORATION DRILLING UPDATE
VANCOUVER, BC, Aug. 31, 2026 /PRNewswire/ -- Nevada King Gold Corp. (TSXV: NKG) (OTCQX: NKGFF) ("Nevada King" or the "Company") is pleased to announce that it has secured a fourth drill rig for its 100% owned, 130km2 Atlanta
More news about: Nevada King Gold Corp.
Aug 20, 2026, 17:00 ET NEVADA KING ANNOUNCES RESULTS OF SHAREHOLDER MEETING
VANCOUVER, BC, Aug. 20, 2026 /PRNewswire/ -- Nevada King Gold Corp. (TSXV: NKG) (OTCQX: NKGFF) ("Nevada King" or the "Company") is pleased to announce that, at its meeting of Shareholders (the "Shareholders")
More news about: Nevada King Gold Corp.
Aug 18, 2026, 20:15 ET CARsgen Therapeutics Announces 2026 Interim Results
In addition, multiple products against different targets are currently under development: CT1390B against CLL1 for AML; KJ-C2526 against NKG2DL for AML, other malignancies and senescence; KJ-C2527 against Claudin18.2 for G/GEJA, etc.; KJ-C2630 against GPC3 for hepatocellular carcinoma (HCC),
More news about: CARsgen Therapeutics
Aug 10, 2026, 02:36 ET Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma
differentiated Nectin-4 ADC developed in solid tumours, lacutamab, an anti-KIR3DL2 antibody developed in cutaneous T cell lymphomas and monalizumab, an anti-NKG2A antibody developed in collaboration with AstraZeneca in non-small cell lung cancer (NSCLC).Sobi®Sobi is a global biopharma company
More news about: Swedish Orphan Biovitrum AB
Aug 10, 2026, 02:32 ET Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma
differentiated Nectin-4 ADC developed in solid tumours, lacutamab, an anti-KIR3DL2 antibody developed in cutaneous T cell lymphomas and monalizumab, an anti-NKG2A antibody developed in collaboration with AstraZeneca in non-small cell lung cancer (NSCLC).Sobi®Sobi is a global biopharma company
More news about: Swedish Orphan Biovitrum AB
Jul 16, 2026, 06:30 ET NEVADA KING RECEIVES BLM APPROVAL FOR 482 ADDITIONAL DRILL SITES, ADDS THIRD DRILL RIG TO ACCELERATE FULLY FUNDED 40,000M DRILL PROGRAM
VANCOUVER, BC, July 16, 2026 /PRNewswire/ -- Nevada King Gold Corp. (TSXV: NKG) (OTCQX: NKGFF) ("Nevada King" or the "Company") is pleased to announce that it has received approval from the Bureau of Land Management
More news about: Nevada King Gold Corp.
Jul 07, 2026, 06:30 ET NEVADA KING INTERCEPTS 4.68 G/T AU OVER 7.3M AND 1.00 G/T AU OVER 26.8M NEAR SURFACE AND BOTTOMING IN MINERALIZATION AT EAST RIDGE TARGET
VANCOUVER, BC, July 7, 2026 /PRNewswire/ - Nevada King Gold Corp. (TSXV: NKG) (OTCQX: NKGFF) ("Nevada King" or the "Company") is pleased to provide an update from its ongoing Rotary Air Blast ("RAB") reconnaissance
More news about: Nevada King Gold Corp.
Jun 26, 2026, 06:30 ET NEVADA KING GRADUATES TO THE PREMIUM OTCQX BEST MARKET, ENHANCING VISIBILITY FOR U.S. INVESTORS
VANCOUVER, BC, June 26, 2026 /PRNewswire/ - Nevada King Gold Corp. (TSXV: NKG) (OTCQX: NKGFF) ("Nevada King" or the "Company") is pleased to announce that its common shares have been approved to begin trading today
More news about: Nevada King Gold Corp.
May 04, 2026, 17:00 ET NEVADA KING TO EFFECT SHARE CONSOLIDATION
VANCOUVER, BC, May 4, 2026 /PRNewswire/ - Nevada King Gold Corp. (TSXV: NKG) (OTCQB: NKGFF) ("Nevada King" or the "Company") is pleased to announce that, further to its news release dated April 10, 2026 and pursuant
More news about: Nevada King Gold Corp.
Apr 28, 2026, 06:30 ET NEVADA KING DOUBLES PHASE 4 DRILL PROGRAM TO 40,000 METRES, PROVIDES ASSAY RESULTS FROM SILVER PARK, AND A PROJECT WIDE PERMITTING UPDATE
VANCOUVER, BC, April 28, 2026 /PRNewswire/ - Nevada King Gold Corp. (TSXV: NKG) (OTCQB: NKGFF) ("Nevada King" or the "Company") is pleased to provide a comprehensive update on its exploration and permitting activities
More news about: Nevada King Gold Corp.
Mar 06, 2026, 07:03 ET CARsgen Therapeutics Announces 2025 Annual Results
and THANK-u Plus™ platform. THANK-u Plus™ platform, as an enhanced version of THANK-uCAR®, was developed to address the potential impact of NKG2A expression levels on therapeutic efficacy of the allogeneic CAR T-cells.CT0596 is a BCMA-targeting allogeneic CAR T-cell product candidate deploying
More news about: CARsgen Therapeutics
Feb 03, 2026, 06:30 ET NEVADA KING EXPANDS SILVER PARK EAST MINERALIZATION WITH 350M STEP-OUT, INTERCEPTS 0.93 G/T AUEQ OVER 14.6M STARTING AT SURFACE
VANCOUVER, BC, Feb. 3, 2026 /PRNewswire/ - Nevada King Gold Corp. (TSXV: NKG) (OTCQB: NKGFF) ("Nevada King" or the "Company") is pleased to announce assay results at the Silver Park East ("SPE") target, located
More news about: Nevada King Gold Corp.
Dec 29, 2025, 06:30 ET NEVADA KING REVIEWS 2025 ACHIEVEMENTS AND 2026 EXPLORATION STRATEGY
VANCOUVER, BC, Dec. 29, 2025 /PRNewswire/ - Nevada King Gold Corp. (TSXV: NKG) (OTCQB: NKGFF) ("Nevada King" or the "Company") is pleased to provide a summary of its key accomplishments during 2025 and review its
More news about: Nevada King Gold Corp.
Dec 28, 2025, 19:10 ET CARsgen Submits Dual IND Applications for Allogeneic BCMA CAR-T Product CT0596
allogeneic CAR T-cell therapy targeting BCMA, developed based on CARsgen's proprietary THANK-u Plus™ platform. Through the knockout of genes such as NKG2A, TRAC, and B2M, CT0596 is designed to reduce the risk of graft-versus-host disease (GvHD) and host immune rejection. Additional gene editing further
More news about: CARsgen Therapeutics
Dec 15, 2025, 08:30 ET Leucid Bio and Syenex Announce Strategic Collaboration for In Vivo CAR-T Cell Engineering
www.leucid.com.About LEU011LEU011 is a lateral CAR-T cell therapy targeting NKG2D stress ligands, which are overexpressed on more than 80% of human tumour types and the cells within the surrounding tumour microenvironment. In addition
More news about: Leucid Bio
Dec 11, 2025, 06:30 ET NEVADA KING ANNOUNCES FULLY FUNDED 20,000M, PHASE 4 EXPLORATION PROGRAM DESIGNED TO ADVANCE MULTIPLE REGIONAL TARGETS IDENTIFIED IN PHASE 3
VANCOUVER, BC, Dec. 11, 2025 /PRNewswire/ - Nevada King Gold Corp. (TSXV: NKG) (OTCQB: NKGFF) ("Nevada King" or the "Company") is pleased to announce the launch of its fully-funded Phase 4 regional exploration
More news about: Nevada King Gold Corp.
Dec 07, 2025, 21:08 ET CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting
dose-escalation phase who received CT0596 infusion. The median number of prior lines of therapy was 4.5 (range: 3-9). Enrollment was not restricted by NKG2A expression levels. Regarding lymphodepletion, 6 patients received full-dose lymphodepletion with fludarabine (30 mg/m²/day) and cyclophosphamide (500
More news about: CARsgen Therapeutics
Dec 07, 2025, 19:15 ET CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting
dose-escalation phase who received CT0596 infusion. The median number of prior lines of therapy was 4.5 (range: 3-9). Enrollment was not restricted by NKG2A expression levels. Regarding lymphodepletion, 6 patients received full-dose lymphodepletion with fludarabine (30 mg/m²/day) and cyclophosphamide (500
More news about: CARsgen Therapeutics
Dec 03, 2025, 06:00 ET NEVADA KING COMPLETES PURCHASE OF SILVER PARK PATENTED MINING CLAIMS
VANCOUVER, BC, Dec. 3, 2025 /PRNewswire/ - Nevada King Gold Corp. (TSX-V: NKG; OTCQB: NKGFF) ("Nevada King" or the "Company") is pleased to announce that it has completed the purchase of the Silver Park claims after
More news about: Nevada King Gold Corp.
Nov 14, 2025, 20:00 ET NEVADA KING ENGAGES INVESTOR RELATIONS FIRM
VANCOUVER, BC, Nov. 14, 2025 /PRNewswire/ - Nevada King Gold Corp. (TSXV: NKG) (OTCQB: NKGFF) ("Nevada King" or the "Company") is pleased to announce that it has engaged Outside The Box Capital Inc. ("Outside The
More news about: Nevada King Gold Corp.
Nov 10, 2025, 06:30 ET NEVADA KING EXTENDS MINERALIZATION 150M ALONG STRIKE AT SILVER PARK EAST
VANCOUVER, BC, Nov. 10, 2025 /PRNewswire/ -- Nevada King Gold Corp. (TSX-V: NKG; OTCQB: NKGFF) ("Nevada King" or the "Company") is pleased to announce results for the remaining 10 holes at its Silver Park East target
More news about: Nevada King Gold Corp.
Nov 10, 2025, 03:30 ET Leucid Bio Provides Update on Phase I/IIa AERIAL Trial Evaluating Lateral CAR-T LEU011 for the Treatment of Solid Tumours
which establish proof-of-concept for LEU011 in the treatment of solid tumours. Furthermore, they highlight LEU011's dual mechanism of action targeting NKG2D stress ligands for tumour recognition and using CXCR2 signalling to enhance T-cell infiltration into the tumour microenvironment."
More news about: Leucid Bio
Nov 03, 2025, 06:30 ET NEVADA KING ANNOUNCES JUSTIN DALEY AS VICE PRESIDENT EXPLORATION
VANCOUVER, BC, Nov. 3, 2025 /PRNewswire/ - Nevada King Gold Corp. (TSXV: NKG) (OTCQB: NKGFF) ("Nevada King" or the "Company") is pleased to announce the appointment of Justin Daley as the Company's Vice President
More news about: Nevada King Gold Corp.
Oct 21, 2025, 06:30 ET NEVADA KING BEGINS DRILLING NEWLY DISCOVERED MULTI-KILOMETER VEIN CORRIDOR AT "WESTERN RIM" TARGET
VANCOUVER, BC, Oct. 21, 2025 /PRNewswire/ - Nevada King Gold Corp. (TSXV: NKG) (OTCQB: NKGFF) ("Nevada King" or the "Company") has initiated drilling at the Western Rim Target, a large and newly defined multidirectional
More news about: Nevada King Gold Corp.
Oct 15, 2025, 17:00 ET NEVADA KING GRADUATES TO TIER 1 OF THE TSX VENTURE EXCHANGE
VANCOUVER, BC, Oct. 15, 2025 /PRNewswire/ - Nevada King Gold Corp. (TSXV: NKG) (OTCQB: NKGFF) ("Nevada King" or the "Company") is pleased to announce that it has received approval to graduate from Tier 2 to Tier 1
More news about: Nevada King Gold Corp.